Cargando…
Visfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism
Increasing evidences suggested visfatin, a newly discovered obesity-induced adipocytokine, is involved in promotion of cancer malignancy and correlated with worse clinical prognosis. While its effects and mechanisms on progression of colorectal cancer (CRC) remain unclear. Our clinical data show tha...
Autores principales: | Yang, Jing, Zhang, Kun, Song, Haixing, Wu, Mingbo, Li, Jingyi, Yong, Ziyi, Jiang, Sheng, Kuang, Xi, Zhang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078014/ https://www.ncbi.nlm.nih.gov/pubmed/27058759 http://dx.doi.org/10.18632/oncotarget.8615 |
Ejemplares similares
-
Visfatin level in patients with colorectal adenoma
por: Fazeli, Mohammad Sadegh, et al.
Publicado: (2016) -
Serum Amyloid a Promotes Visfatin Expression in Macrophages
por: Wang, Shixun, et al.
Publicado: (2016) -
Visfatin Mediates Malignant Behaviors through Adipose-Derived Stem Cells Intermediary in Breast Cancer
por: Huang, Jyun-Yuan, et al.
Publicado: (2019) -
DSTYK Promotes Metastasis and Chemoresistance via EMT in Colorectal Cancer
por: Zhang, Jinyu, et al.
Publicado: (2020) -
Circulating visfatin level and visfatin/insulin ratio in obese women with metabolic syndrome
por: Olszanecka-Glinianowicz, Magdalena, et al.
Publicado: (2012)